Tucson, Arizona Introduction. Reported associations between condom use and human papillomavirus (HPV) infection in men have been inconsistent.
Human papillomavirus (HPV) is the most common sexually transmitted pathogen and is the cause of cervical cancer. An estimated 6.2 million people in the United States acquired a genital HPV infection in 2000 [1] . Approximately 60 HPV genotypes are known to infect the genital tract, one-third of which are considered "high risk" or oncogenic [2] . Although infection is most often asymptomatic and transient, oncogenic genotypes of HPV are strongly associated with cervical cancer and are associated with other anogenital cancers in both men and women to varying degrees [3] . Nononcogenic HPV types can cause genital warts and other benign lesions.
Reported determinants of HPV infection in men have included age, sexual behavior and history, use of condoms, history of other sexually transmitted infections, circumcision status, ethnicity, and education level [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . When condom use has been evaluated, it is usually not associated with HPV infection in men, although a protective association against genital warts has been reported [16] . However, many studies combine sampling from areas not covered by a condom, thus diluting any effect that might logically be expected. For example, studies that included swab samples from the scrotum [10, 11] found no effect of condom use. Hippelainen et al [8] sampled the urethra and penile epithelium and did note a protective effect. However, another study that sampled the same sites sampled failed to find a protective effect [7] .
In the current analysis, HPV infection in asymptomatic men was determined at 1 time point for 5 anatomic sites separately: glans penis and/or coronal sulcus, pen- ile shaft, scrotum, perianal area, and anal canal. A health and sexual behaviors questionnaire, which included several questions regarding condom use, was self-administered. The associations between frequency of condom use during vaginal sex and presence of HPV overall and at each anatomic site were determined. The hypothesis that these associations might differ by number of recent partners (1 vs 11) was tested.
SUBJECTS, MATERIALS, AND METHODS
The study design, study population, clinical sampling, and HPV testing procedures have been described in detail elsewhere [17] . Briefly, a cross-sectional study of HPV infection in 463 men recruited in Tucson, Arizona, and Tampa, Florida, was undertaken. Primary methods of recruitment were through advertisements in city and university newspapers, flyers in public places, and in-person recruitment at the local air force base and the county health department sexually transmitted disease (STD) clinic. Men were eligible if they (1) were between 18 and 40 years old, (2) had had sexual intercourse with a woman within the past year, (3) had no previous diagnosis of genital warts or penile or anal cancer, (4) had no current penile discharge or pain during urination, and (5) had no current diagnosis of a sexually transmitted disease. All participants gave informed consent, and all procedures were approved by the Institutional Review Boards at the University of Arizona, Centers for Disease Control and Prevention, United States Department of Defense, and the University of South Florida. The study clinician examined each participant's genital, abdominal, and anal areas and recorded the number and location of any lesions or warts. These were sampled by rubbing with a saline-wetted polyester-fiber-tipped swab. The clinician also recorded the presence and location of any erythema, abrasions, rashes, inflammation, discharge, or piercings in the same regions and whether the participant was circumcised. Other anogenital sites were sampled by rubbing separate saline-wetted polyester-fiber-tipped swabs of the entire surface of (1) the glans penis and/or coronal sulcus, (2) the penile shaft (including prepuce, if present), (3) the scrotum, and (4) the perianal area. To sample the anal canal, a separate saline-wetted polyester-fiber-tipped swab was inserted ∼2 cm into the anal canal.
All men also completed a self-administered questionnaire, which included questions about demographic characteristics, sexual history, and sexual behavior questions. Specifically, they were asked how many sexual partners of each sex they had had in their lifetime and in the past 3 months. They were also asked the frequency of condom use during vaginal sex with any part- ner in the past 3 months ("always," "more than half the time," "half the time," "less than half the time," and "never"). Because the question of condom use covered the previous 3 months, for this analysis we excluded men who had not had sex with a woman within the previous 3 months. HPV DNA detection and genotyping. HPV testing of swabbed cellular material was conducted using polymerase chain reaction (PCR) for amplification of a fragment of the L1 gene [18] . HPV genotyping was conducted using the reverse line blot method [19] on all samples, regardless of HPV PCR result. This detection method utilizes the HPV L1 consensus PCR products labeled with biotin to detect 37 HPV types. The oncogenic HPV types associated with cervical dysplasia and cancer include 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 66 1 [20] . The nononcogenic types detected with the line blot methodology of Roche are 6, 11, 26, 40, 42, 53-55, 61, 62, 64, 67-73, 81-84, IS39, and CP6108.
Statistical analysis. The presence of any HPV DNA was defined as a positive result by genotyping. The absence of any HPV DNA by genotyping in a sample positive for human bglobin was defined as a negative result. Samples without detection of b-globin were deemed inadequate for evaluation and treated as missing. (Between 93.7% and 95.7% of the external genital and anal samples were adequate.) HPV outcomes were determined separately for (1) all sampling sites combined, (2) each sampling site individually, and (3) the sampling sites that would be covered by a condom (ie, shaft and glans and/or corona) if it were used correctly. The frequencies and mean values of the responses to the questionnaire items and the results from the clinical examination were calculated. These cal- x The associations between frequency of condom use (as a dichotomous "always" vs "not always" variable) and each HPV outcome (oncogenic genotype, nononcogenic genotype, and any genotype) were evaluated using logistic regression. Age and date of HPV analysis were included in all models. Date of HPV laboratory analysis was included to account for improvements in sensitivity over time [21] . Confounding was controlled by retaining in a multivariable model those variables that altered the unadjusted odds ratio (OR) for any of the condom use categories by 110%. Models were developed separately for oncogenic, nononcogenic, and any HPV genotypes, because risk factors have been reported to differ by HPV type [21, 22] . Effect modification by number of partners in the past 3 months (1 vs 11) was hypothesized. Therefore, ORs were compared between the 2 strata. Tests of interaction were performed using likelihood ratio tests of each model with and without the interaction term in the multivariate-adjusted models. was P ! .10 considered statistically significant for the tests of interaction. Analyses were conducted using Intercooled Stata 9.1 software for Windows (StataCorp).
RESULTS
Results of recruitment and the sample's demographic characteristics have been described elsewhere [17] . Briefly, 359 men in Tucson, Arizona, and 104 men in Tampa, Florida, contributed anogenital swab samples. Of these, 393 men reported having had у1 female sexual partner in the past 3 months and were included in this analysis.
Factors associated with baseline health and behavioral characteristics are presented in Table 1 . Men who always used condoms were younger, more likely to be unmarried, and not to have a steady partner. They also reported greater monthly alcohol consumption and were more likely to have had 11 female partner in the past 3 months. Compared with men who used condoms more frequently, a greater proportion of men who reported using condoms less than half the time had genital warts detected at the clinical visit ( Table 1) .
The proportions of HPV-positive samples by frequency of condom use at each sampling site and overall are displayed in Table 2 . There were trends toward greater proportions of HPVpositive samples as condom use frequency declined from "always" to "never" for any HPV type and for both oncogenic and nononcogenic groups when all sampling sites were combined. For any HPV type, the proportion of HPV-positive samples ranged from 37.9% among men who always used condoms to 53.9% among men who never used condoms ( ). P p .008 Results were similar for the combined anatomic sampling sites covered by a condom (the glans and/or corona and shaft), and the trend was statistically significant for each of these 2 sites individually. For all categories of HPV, the proportion of men with an HPV-positive shaft sample was significantly higher among those who never used condoms than among those who always used condoms ( Table 2 ). The proportions of HPV-positive glans and/or corona and scrotum samples were lower than the proportion of positive shaft samples, and results for trend tests across frequency of condom use categories were inconsistent for glans and/or corona and scrotum sites. That is, trend tests were marginally significant for the glans and/or corona when nononcogenic HPV was considered, but not when oncogenic HPV was considered; and trend tests were significant for scrotum samples when oncogenic HPV was considered, but not when nononcogenic HPV was considered ( Table 2) .
The proportion of samples positive for multiple HPV types was 0-5.8% for the anal sites, and there were no significant differences across the frequency of condom use categories. However, the proportions with multiple HPV types were 9.0%-31.6% for the penile and scrotal sites. Significantly greater proportions of multiple HPV-positive samples were observed for the shaft (P for trend p .005) and covered sites (P for trend p .03). The proportion of multiple-HPV positive samples at the scrotum, glans and/or corona, and all sites combined did not differ significantly by frequency of condom use (P for trend у0.16; data not shown).
The association between any HPV type and always using condoms differed by the number of partners in the past 3 months (Table 3 ). The prevalence of any HPV type among men who reported only 1 partner in the past 3 months was 45.7%, and among men who reported 11 partner, the prevalence was 64.5%. Condom use was not significantly associated with lower HPV detection among men who reported only 1 partner in the past 3 months (adjusted OR, 0.69; 95% confidence interval [CI], 0.38-1.24). However, among men who reported 11 partner, always using condoms was strongly and significantly associated with reduced HPV detection (adjusted OR, 0.22; 95% CI, 0.08-0.59). The interaction term was significant by the likelihood ratio test ( ). For oncogenic types, the inter-P p .05 action was not significant, but the adjusted OR was stronger for men with 11 partner (adjusted OR, 0.23; 95% CI, 0.06-0.85) than it was for men with 1 partner (adjusted OR, 0.50; 95% CI, 0.24-1.04), and the overall association across strata was 0.40 (95% CI, 0.21-0.75). Associations with nononcogenic HPV were similar to those for any HPV type, and the interaction term was significant at the 0.10 a level ( ). P p .07
DISCUSSION
Always using condoms, particularly among men with multiple partners, was strongly associated with lower odds of HPV detection. While the frequencies of HPV-positive samples were higher among men who used condoms less frequently, substantial proportions of men who reported always using condoms nevertheless had HPV-positive samples. For example, for any HPV type, the proportion of positive samples among the "always" group was 37.9%, and among the "never" group it was 53.9%.
Several factors allowed us to evaluate associations with condom use in greater depth than did previous studies of HPV in men. This paper focused on use with any female partner in the previous 3 months, whereas other studies have restricted questions to condom use with prostitutes or regular partners [7, 9] or have not specified a time period for the behavior [8, 13] , which could result in misclassification of exposure. Furthermore, our ability to examine proportion of HPV-positive samples at each anatomic site and at the combined shaft and glans and/or corona sites allowed us to define HPV outcomes more precisely than in those studies that combined penile and scrotum samples to determine a single HPV outcome [10, 11] . We consistently observed less of a difference in proportions of HPV-positive samples by condom use frequency at uncovered sites than at covered sites. Therefore, in studies that combined sites, it is possible that any true protective effect at covered sites might be diluted by a lack of effect at uncovered sites.
A limitation of this study is that an assessment of correct condom usage was not made. Incorrect usage has been reported to be common in college-aged men: for example, 43% reported putting on the condom after starting sex [23] . In an STD clinicbased study, 15% of men reported experiencing condom use errors and problems, which could minimize their protective effect, independently of the reported frequency of condom use [24] . Failure to measure these aspects of use clearly could result in an underestimate of the effectiveness of condoms when used correctly [25] . Furthermore, men who reported a greater number of partners also reported more condom use errors, including not using condoms from the start to the finish of sex [26] . Therefore, information on correct use may contribute to clarifying the degree to which condom use may prevent HPV infection. Future studies that include evaluations of whether condoms were applied before any genital contact and whether they completely covered the shaft of the penis may be useful in additional understanding of the effectiveness of HPV prevention and designing successful interventions [27] .
Other limitations of this study are the cross-sectional nature of the assessment of both condom use and HPV outcomes and the self-report of sensitive personal information. We are unable to make any claims of causality; however, analysis of sexual behaviors, including number of partners and condom use, in a longitudinal cohort study of HPV in asymptomatic men may provide such evidence. One study among men found high reliability (у90% agreement) between responses to sexual activity questions reported for the previous 2 weeks and for the previous 3 months [28] . In the current study, the questionnaire typically asked men to reflect on lifetime sexual history or activities in the past 3 months, and the high reliability of these responses has been reported in this population [29] .
Condom use may contribute to a lower rate of HPV infection at the penile shaft and glans, and if this preventive association is confirmed, it may be an important part of HPV education messages aimed at sexually active men and their partners. This study shows that consistent use is important and that consistent condom users had a 60%-77% lower risk of infection with oncogenic HPV. Future studies on the prevention of HPV through condom use will require particular emphasis on the application of a condom before anogenital contact and on complete coverage of the penile shaft throughout intercourse.
